Unknown

Dataset Information

0

Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens.


ABSTRACT: The induction of broadly neutralizing antibodies (bNAbs) is a major goal in the development of an effective vaccine against HIV-1. A soluble, trimeric, germline (gI) bNAb-targeting variant of the HIV-1 envelope glycoprotein (termed BG505 SOSIP.v4.1-GT1.1 gp140, abbreviated to GT1.1) has recently been developed. Here, we have compared this new immunogen with the parental trimer from which it was derived, BG505 SOSIP.664 gp140. We used a comprehensive suite of biochemical and biophysical methods to determine physicochemical similarities and differences between the 2 trimers, and thereby assessed whether additional formulation development efforts were needed for the GT1.1 vaccine candidate. The overall higher order structure and oligomeric states of the 2 vaccine antigens were quite similar, as were their thermal, chemical, and colloidal stability profiles, as evaluated during accelerated stability studies. Overall, we conclude that the primary sequence changes made to create the gl bNAb-targeting GT1.1 trimer did not detrimentally affect its physicochemical properties or stability profiles from a pharmaceutical perspective. This developability assessment of the BG505 GT1.1 vaccine antigen supports using the formulation and storage conditions previously identified for the parental SOSIP.664 trimer and enables the development of GT1.1 for phase I clinical studies.

SUBMITTER: Whitaker N 

PROVIDER: S-EPMC6595180 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens.

Whitaker Neal N   Hickey John M JM   Kaur Kawaljit K   Xiong Jian J   Sawant Nishant N   Cupo Albert A   Lee Wen-Hsin WH   Ozorowski Gabriel G   Medina-Ramírez Max M   Ward Andrew B AB   Sanders Rogier W RW   Moore John P JP   Joshi Sangeeta B SB   Volkin David B DB   Dey Antu K AK  

Journal of pharmaceutical sciences 20190215 7


The induction of broadly neutralizing antibodies (bNAbs) is a major goal in the development of an effective vaccine against HIV-1. A soluble, trimeric, germline (gI) bNAb-targeting variant of the HIV-1 envelope glycoprotein (termed BG505 SOSIP.v4.1-GT1.1 gp140, abbreviated to GT1.1) has recently been developed. Here, we have compared this new immunogen with the parental trimer from which it was derived, BG505 SOSIP.664 gp140. We used a comprehensive suite of biochemical and biophysical methods t  ...[more]

Similar Datasets

| S-EPMC5852640 | biostudies-literature
| S-EPMC5841823 | biostudies-literature
| S-EPMC5023125 | biostudies-literature
| S-EPMC4442528 | biostudies-literature
| S-EPMC3777863 | biostudies-literature
| S-EPMC5389922 | biostudies-literature
| S-EPMC7925178 | biostudies-literature
| S-EPMC5660478 | biostudies-literature
| S-EPMC4524223 | biostudies-literature
| S-EPMC7308430 | biostudies-literature